Lipid-rich diet enhances L-cell density in obese subjects and in mice through improved L-cell differentiation

Journal of Nutritional Science

Volumn 4, Issue , 2015, Pages

  Aranias, Thomas ^a   Grosfeld, Alexandra ^a,b   Poitou, Christine ^b,c   Omar, Amal Ait ^a   Le Gall, Maude ^a,d   Miquel, Sylvie ^e   Garbin, Kévin ^a   Ribeiro, Agnès ^a,b   Bouillot, Jean Luc ^f   Bado, André ^d   Brot Laroche, Edith ^a,b   Clément, Karine ^b,c   Leturque, Armelle ^a,b   Guilmeau, Sandra ^d,g   Serradas, Patricia ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c INSERM   (France)

^d CENTRE DE RECHERCHE SUR L INFLAMMATION   (France)

^e UMR1319 MICALIS   (France)

^f HÔPITAL AMBROISE PARÉ   (France)

^g INSTITUT COCHIN   (France)

Author keywords

Enteroendocrine cells; Gut hormones; High fat diet; Intestine

Indexed keywords

ANTIBIOTIC AGENT; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLITAZONE DERIVATIVE; GLUCAGON LIKE PEPTIDE 1; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; HEPATOCYTE NUCLEAR FACTOR 3BETA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INCRETIN; INSULIN; MESSENGER RNA; METFORMIN; PEPTIDE YY; PREPROGLUCAGON; SULFONYLUREA DERIVATIVE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CARBOHYDRATE DIET; CELL DENSITY; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL PROLIFERATION; COLON; CONTROLLED STUDY; DYSLIPIDEMIA; ENTEROENDOCRINE CELL; FAT INTAKE; FLOW CYTOMETRY; FOOD COMPOSITION; FOOD INTAKE; GASTRIC BYPASS SURGERY; HELICOBACTER INFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INSULIN LIKE ACTIVITY; INSULIN RELEASE; INSULIN RESISTANCE; JEJUNUM; L CELL LINE; LIPID DIET; MALE; MORBID OBESITY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITIONAL STATUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION;

EID: 84994632130     PISSN: 20486790     EISSN: None     Source Type: Journal    
DOI: 10.1017/jns.2015.11     Document Type: Article

References (38)

1. Helander HF & Fändriks L (2012) The enteroendocrine "letter cells" - time for a new nomenclature? Scand J Gastroenterol 47, 3-12.
2. Drucker DJ (2013) Incretin action in the pancreas: potential promise, possible perils, and pathological pitfalls. Diabetes 62, 3316-3323.
3. Mellitzer G, Beucher A, Lobstein V, et al. (2010) Loss of enteroendocrine cells in mice alters lipid absorption and glucose homeostasis and impairs postnatal survival. J Clin Invest 120, 1708-1721.
4. Gribble FM (2012) The gut endocrine system as a coordinator of postprandial nutrient homoeostasis. Proc Nutr Soc 71, 456-462.
5. Holst JJ (2007) The physiology of glucagon-like peptide 1. Physiol Rev 87, 1409-1439.
6. Nauck MA, Vardarli I, Deacon CF, et al. (2011) Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down? Diabetologia 54, 10-18.
7. Diakogiannaki E, Gribble FM & Reimann F (2012) Nutrient detection by incretin hormone secreting cells. Physiol Behav 106, 387-393.
8. Cani PD, Hoste S, Guiot Y, et al. (2007) Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. Br J Nutr 98, 32-37.
9. Everard A & Cani PD (2013) Diabetes, obesity and gut microbiota. Best Pract Res Clin Gastroenterol 27, 73-83.
10. van der Flier LG & Clevers H (2009) Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol 71, 241-260.
11. Schonhoff SE, Giel-Moloney M & Leiter AB (2004) Minireview: development and differentiation of gut endocrine cells. Endocrinology 145, 2639-2644.
12. Jenny M, Uhl C, Roche C, et al. (2002) Neurogenin3 is differentially required for endocrine cell fate specification in the intestinal and gastric epithelium. EMBO J 21, 6338-6347.
13. Ye DZ & Kaestner KH (2009) Foxa1 and Foxa2 control the differentiation of goblet and enteroendocrine L- and D-cells in mice. Gastroenterology 137, 2052-2062.
14. Roth KA, Hertz JM & Gordon JI (1990) Mapping enteroendocrine cell populations in transgenic mice reveals an unexpected degree of complexity in cellular differentiation within the gastrointestinal tract. J Cell Biol 110, 1791-1801.
15. Habib AM, Richards P, Cairns LS, et al. (2012) Overlap of endocrine hormone expression in the mouse intestine revealed by transcriptional profiling and flow cytometry. Endocrinology 153, 3054-3065.
16. Anini Y & Brubaker PL (2003) Role of leptin in the regulation of glucagon-like peptide-1 secretion. Diabetes 52, 252-259.
17. Rocca AS, LaGreca J, Kalitsky J, et al. (2001) Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1. Endocrinology 142, 1148-1155.
18. Schmitz G & Langmann T (2006) Metabolic learning in the intestine: adaptation to nutrition and luminal factors. Horm Metab Res 38, 452-454.
19. Pyarokhil AH, Ishihara M, Sasaki M, et al. (2012) The developmental plasticity of colocalization pattern of peptide YY and glucagonlike peptide-1 in the endocrine cells of bovine rectum. Biomed Res 33, 35-38.
20. Gniuli D, Calcagno A, Dalla Libera L, et al. (2010) High-fat feeding stimulates endocrine, glucose-dependent insulinotropic polypeptide (GIP)-expressing cell hyperplasia in the duodenum of Wistar rats. Diabetologia 53, 2233-2240.
21. Petersen N, Reimann F, van Es JH, et al. (2015) Targeting development of incretin-producing cells increases insulin secretion. J Clin Invest 125, 379-385.
22. Sakar Y, Duca FA, Langelier B, et al. (2014) Impact of high-fat feeding on basic helix-loop-helix transcription factors controlling enteroendocrine cell differentiation. Int J Obes (Lond) 38, 1440-1448.
23. Hill ME, Asa SL & Drucker DJ (1999) Essential requirement for Pax6 in control of enteroendocrine proglucagon gene transcription. Mol Endocrinol 13, 1474-1486.
24. Wang M & Drucker DJ (1995) The LIM domain homeobox gene isl-1 is a positive regulator of islet cell-specific proglucagon gene transcription. J Biol Chem 270, 12646-12652.
25. Moreira AP, Texeira TF, Ferreira AB, et al. (2012) Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr 108, 801-809.
26. Mistry AM, Swick AG & Romsos DR (1997) Leptin rapidly lowers food intake and elevates metabolic rates in lean and ob/ob mice. J Nutr 127, 2065-2072.
27. Pan H, Guo J & Su Z (2014) Advances in understanding the interrelations between leptin resistance and obesity. Physiol Behav 130C, 157-169.
28. Cummings JH, Wiggins HS, Jenkins DJ, et al. (1978) Influence of diets high and low in animal fat on bowel habit, gastrointestinal transit time, fecal microflora, bile acid, and fat excretion. J Clin Invest 61, 953-963.
29. Parker HE, Wallis K, le Roux CW, et al. (2012) Molecular mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion. Br J Pharmacol 165, 414-423.
30. Potthoff MJ, Potts A, He T, et al. (2013) Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice. Am J Physiol Gastrointest Liver Physiol 304, G371-G380.
31. Tolhurst G, Heffron H, Lam YS, et al. (2012) Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 61, 364-371.
32. Lin HV, Frassetto A, Kowalik EJ Jr, et al. (2012) Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLOS ONE 7, e35240.
33. Yadav H, Lee JH, Lloyd J, et al. (2013) Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. J Biol Chem 288, 25088-25097.
34. Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, et al. (2009) High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 137, 1716-1724.e2.
35. Calviello G, Palozza P, Maggiano N, et al. (1999) Cell proliferation, differentiation, and apoptosis are modified by n-3 polyunsaturated fatty acids in normal colonic mucosa. Lipids 34, 599-604.
36. Krey G, Braissant O, L'Horset F, et al. (1997) Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol 11, 779-791.
37. Forman BM, Chen J & Evans RM (1997) Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc Natl Acad Sci U S A 94, 4312-4317.
38. Daoudi M, Hennuyer N, Borland MG, et al. (2011) PPARβ/δ activation induces enteroendocrine L cell GLP-1 production. Gastroenterology 140, 1564-1574.